Dex and the Cytokine City: Managing CRS with Bispecifics

https://is1-ssl.mzstatic.com/image/thumb/Podcasts116/v4/44/1e/84/441e8404-cfcd-d5ea-5cd7-20bcae5f4165/mza_9369316362601325051.jpg/600x600bb.jpg

WolverHeme Happy Hour

Bernard Marini, Anthony Perissinotti, et al.

41 episodes

3 days ago

Welcome to WolverHeme Happy Hour! This is a podcast dedicated to all things hematology! We discuss new data, debate controversial therapies, and talk about new and exciting research. While we nerd out about data, we'll have a few drinks! Disclaimer: The views and opinions expressed on this podcast are solely those of the podcasters and guests and do not reflect the views or opinions of our employers or other affiliations.

Medicine

Health & Fitness

RSS

All content for WolverHeme Happy Hour is the property of Bernard Marini, Anthony Perissinotti, et al. and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.

Medicine

Health & Fitness

https://d3t3ozftmdmh3i.cloudfront.net/production/podcast_uploaded_nologo/22883740/22883740-1646962011003-b3603219ae0ba.jpg

Dex and the Cytokine City: Managing CRS with Bispecifics

WolverHeme Happy Hour

59 minutes 51 seconds

7 months ago

Dex and the Cytokine City: Managing CRS with Bispecifics

In this episode, Bernie and Anthony are joined by 3 hematology pharmacists - James Davis, PharmD, BCOP; Victoria Nachar, PharmD, BCOP; and Justine Preedit, PharmD, BCOP - to discuss the optimal management of CRS in patients receiving bispecific antibodies!

Inspired by this recent paper:

https://www.nature.com/articles/s41408-025-01222-y